Cargando…
Gene Expression Signatures Identify Biologically Homogenous Subgroups of Grade 2 Meningiomas
INTRODUCTION: Meningiomas are the most common brain tumor, with prevalence of approximately 3%. Histological grading has a major role in determining treatment choice and predicting outcome. While indolent grade 1 and aggressive grade 3 meningiomas exhibit relatively homogeneous clinical behavior, gr...
Autores principales: | Zador, Zsolt, Landry, Alexander P., Saha, Ashirbani, Cusimano, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674612/ https://www.ncbi.nlm.nih.gov/pubmed/33224871 http://dx.doi.org/10.3389/fonc.2020.541928 |
Ejemplares similares
-
Landscape of immune cell gene expression is unique in predominantly WHO grade 1 skull base meningiomas when compared to convexity
por: Zador, Zsolt, et al.
Publicado: (2020) -
Meta-gene markers predict meningioma recurrence with high accuracy
por: Zador, Zsolt, et al.
Publicado: (2020) -
Specific gene expression signatures of low grade meningiomas
por: Tsitsikov, Erdyni N., et al.
Publicado: (2023) -
New drug candidates for treatment of atypical meningiomas: An integrated approach using gene expression signatures for drug repurposing
por: Zador, Zsolt, et al.
Publicado: (2018) -
Multimorbidity states associated with higher mortality rates in organ dysfunction and sepsis: a data-driven analysis in critical care
por: Zador, Zsolt, et al.
Publicado: (2019)